Logothetis CJ - Search Results

1

TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.

Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. Clin Cancer Res. 2000 Mar;6(3):1190-7. Clin Cancer Res. 2000. PMID: 10741751

2

Human prostate cancer model: roles of growth factors and extracellular matrices.

Chung LW, Li W, Gleave ME, Hsieh JT, Wu HC, Sikes RA, Zhau HE, Bandyk MG, Logothetis CJ, Rubin JS, et al. Chung LW, et al. Among authors: logothetis cj. J Cell Biochem Suppl. 1992;16H:99-105. doi: 10.1002/jcb.240501222. J Cell Biochem Suppl. 1992. PMID: 1289680 Review.

3

Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.

Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF. Logothetis CJ, et al. J Natl Cancer Inst. 1992 Aug 19;84(16):1256-61. doi: 10.1093/jnci/84.16.1256. J Natl Cancer Inst. 1992. PMID: 1640485

4

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

5

The clinical and biological study of androgen independent prostate cancer (AI PCa).

Logothetis CJ, Hoosein NM, Hsieh JT. Logothetis CJ, et al. Semin Oncol. 1994 Oct;21(5):620-9. Semin Oncol. 1994. PMID: 7524155 Review. No abstract available.

6

Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines.

Abdul M, Logothetis CJ, Hoosein NM. Abdul M, et al. Among authors: logothetis cj. J Urol. 1995 Jul;154(1):247-50. J Urol. 1995. PMID: 7776439

7

Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists.

Abdul M, Anezinis PE, Logothetis CJ, Hoosein NM. Abdul M, et al. Among authors: logothetis cj. Anticancer Res. 1994 May-Jun;14(3A):1215-20. Anticancer Res. 1994. PMID: 8074475

8

Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer.

Sella A, Aggarwal BB, Kilbourn RG, Bui CA, Zukiwski AA, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. Cancer Biother. 1995 Fall;10(3):225-35. doi: 10.1089/cbr.1995.10.225. Cancer Biother. 1995. PMID: 8547961 Clinical Trial.

9

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. McDonnell TJ, et al. Among authors: logothetis cj. J Urol. 1997 Feb;157(2):569-74. J Urol. 1997. PMID: 8996359

10

Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer.

Tu SM, Pagliaro LC, Banks ME, Amato RJ, Millikan RE, Bugazia NA, Madden T, Newman RA, Logothetis CJ. Tu SM, et al. Among authors: logothetis cj. Clin Cancer Res. 1998 May;4(5):1193-201. Clin Cancer Res. 1998. PMID: 9607577 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters